Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
ASMB has been in the news recently: Assembly Biosciences is not directly mentioned in the provided information. However, it is important to note that the article discusses various unrelated topics such as a casino proposal near Citi Field, California's AB 408 regarding troubled doctors, and a fraud ring in Los Angeles. If you need information specifically about Assembly Biosciences or its relevant entities, please provide related content.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
